DOI:
10.1055/s-00034914
Osteologie
LinksClose Window
References
Murakami K, Kobayashi Y, Uehara S. et al.
A Jak1/2 inhibitor, baricitinib, inhibits osteoclastogenesis by
suppressing RANKL expression in osteoblasts in vitro.
PLoS One 2017;
12: e0181126
DOI: 10.1371/journal.pone.0181126.
We do not assume any responsibility for the contents of the web pages of other providers.